These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22452410)

  • 1. Late onset renal failure and nephrotic syndrome after autologous stem cell transplant for Al amyloidosis.
    Rifkin SI; Weinstein SS
    Ren Fail; 2012; 34(5):664-6. PubMed ID: 22452410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.
    Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z
    Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation.
    Van Steenbergen W; Braeye L; Harlet R; Nevens F; Fevery J; Desmet V; Roskams T; Pirenne J
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1265-70. PubMed ID: 20729743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous Stem Cell Transplantation in Patients With Primary Systemic Amyloidosis: Experience of a Tertiary Hospital.
    Domínguez-Muñoz MA; Calderón-Cabrera C; Martino-Galiana ML; Martín-Sánchez J
    Transplant Proc; 2015 Nov; 47(9):2661-4. PubMed ID: 26680066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory profile of renal amyloidosis: A single-center experience.
    Engineer DP; Kute VB; Patel HV; Shah PR
    Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary systemic AL amyloidosis with remarkable calcification in the spleen].
    Uchiyama K; Tsukada N; Miyazaki K; Abe Y; Sekine R; Nakagawa Y; Suzuki K
    Rinsho Ketsueki; 2014 Mar; 55(3):334-9. PubMed ID: 24681937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of nephrotic syndrome and lack of progression of heroin-associated renal amyloidosis.
    Crowley S; Feinfeld DA; Janis R
    Am J Kidney Dis; 1989 Apr; 13(4):333-5. PubMed ID: 2705451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of acute renal failure and nephrotic syndrome following autologous stem cell transplantation for primary (AL) amyloidosis.
    Snanoudj R; Mamzer-Bruneel MF; Hermine O; Grunfeld JP; Chauveau D
    Nephrol Dial Transplant; 2003 Oct; 18(10):2175-7. PubMed ID: 13679499
    [No Abstract]   [Full Text] [Related]  

  • 12. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal failure and nephrotic syndrome associated with gastrointestinal stromal tumour (GIST)-a rare cause of AA amyloidosis.
    Jaakkola H; Törnroth T; Groop PH; Honkanen E
    Nephrol Dial Transplant; 2001 Jul; 16(7):1517-8. PubMed ID: 11427662
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
    Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
    J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
    Herrmann SM; Gertz MA; Stegall MD; Dispenzieri A; Cosio FC; Kumar S; Lacy MQ; Dean PG; Prieto M; Zeldenrust SR; Buadi FK; Russell SJ; Nyberg SL; Hayman SR; Dingli D; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2011 Jun; 26(6):2032-6. PubMed ID: 21543655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal failure due to primary amyloidosis: a case report and literature review.
    de Mello RA; Marques Santos DS; Freitas-Silva MP; Andrade JA
    Sao Paulo Med J; 2011 May; 129(3):176-80. PubMed ID: 21755253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-one years survival with systemic AL-amyloidosis.
    Goldsmith DJ; Sandooran D; Short CD; Mallick NP; Johnson RW
    Am J Kidney Dis; 1996 Aug; 28(2):278-82. PubMed ID: 8768926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
    Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
    Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term remission of renal amyloidosis with nephrotic syndrome after autologous peripheral blood stem-cell transplantation.
    Ogawa K; Ikeda K; Furukawa M; Harada-Shirado K; Mashimo Y; Takahashi H; Matsumoto H; Kimura S; Shichishima-Nakamura A; Ohkawara H; Hashimoto Y; Asahi K; Noji H; Ohto H; Takeishi Y
    Fukushima J Med Sci; 2010 Dec; 56(2):151-6. PubMed ID: 21502717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review.
    Giannese D; Ferro F; Moriconi D; Bonadio AG; Elefante E; Egidi MF; Cupisti A; Baldini C
    CEN Case Rep; 2021 Feb; 10(1):23-29. PubMed ID: 32681397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.